Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Behavioral addiction

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44349   clinical trials with a EudraCT protocol, of which   7376   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    40 result(s) found for: Behavioral addiction. Displaying page 1 of 2.
    1  2  Next»
    EudraCT Number: 2018-000420-34 Sponsor Protocol Number: CHUB-NAC-Craving Start Date*: 2018-11-27
    Sponsor Name:Centre Hospitalier Universitaire Brugmann
    Full Title: Efficacy of N-acetylcysteine on the craving symptoms of hospitalized patients with cocaine addiction.
    Medical condition: Cocaine addiction
    Disease: Version SOC Term Classification Code Term Level
    20.1 100000004873 10009817 Cocaine dependence LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2011-001088-28 Sponsor Protocol Number: BRIO Start Date*: 2016-01-14
    Sponsor Name:South London and Maudsley NHS Foundation Trust [...]
    1. South London and Maudsley NHS Foundation Trust
    2. King's College London
    Full Title: Feasibility, efficacy and acceptability of injected buprenorphine as treatment for opiate users who persist in injecting illicit heroin through opiate maintenance treatment
    Medical condition: Addiction to illicit heroin
    Disease: Version SOC Term Classification Code Term Level
    18.1 100000004873 10019935 Heroin addiction LLT
    18.1 100000004873 10001127 Addiction to drugs LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2008-001397-32 Sponsor Protocol Number: 2480/2008 Start Date*: 2008-05-14
    Sponsor Name:ASL 5 di PISA-ZONA VALDERA
    Full Title: ARIPIPRAZOLE VERSUS ROPIRINOLE: A PILOT , OPEN-LABEL, PROSPECTIVE, RANDOMISED, CONTROLLED, MULTICENTRIC TRIAL, IN THERAPY WITH ROPIRINOLE OR ARIPIPRAZOLE FOR COCAINE DEPENDENCE
    Medical condition: TERAPY FOR COCAINE DEPENDENCE
    Disease: Version SOC Term Classification Code Term Level
    9.1 10009815 Cocaine addiction LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: IT (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2006-004921-27 Sponsor Protocol Number: 1 Start Date*: 2006-12-15
    Sponsor Name:Psykiatrisk Center Gentofte
    Full Title: Antabuse in severe alcoholism: an open controlled study
    Medical condition: Alcoholism
    Disease: Version SOC Term Classification Code Term Level
    8.1 10001639 Alcoholism LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2004-001929-20 Sponsor Protocol Number: TEST-APO Start Date*: 2010-05-18
    Sponsor Name:Servicio de Psiquiatría. Hospital Universitari Vall d’Hebron
    Full Title: EL TEST DE APOMORFINA COMO MARCADOR BIOLÓGICO DE LAS RECAÍDAS EN PACIENTES DEPENDIENTES DE SUSTANCIAS PSICOTROPAS
    Medical condition: Dependencia de alcohol Dependencia de cocaína Dependencia de heroína
    Disease: Version SOC Term Classification Code Term Level
    9 10001590 Alcohol addiction LLT
    9 10009815 Cocaine addiction LLT
    9 10019935 Heroin addiction LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2013-002516-27 Sponsor Protocol Number: P121006 Start Date*: 2014-03-06
    Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
    Full Title:
    Medical condition:
    Disease: Version SOC Term Classification Code Term Level
    18.0 100000004873 10009817 Cocaine dependence LLT
    Population Age: Adults Gender: Male
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2006-006886-18 Sponsor Protocol Number: ALK21-014 Start Date*: 2007-06-04
    Sponsor Name:Alkermes Inc
    Full Title: Efficacy and Safety of Vivitrol® in Adults Completing Inpatient Treatment for Alcohol Dependence
    Medical condition: Alcohol Dependence
    Disease: Version SOC Term Classification Code Term Level
    9.1 10001590 Alcohol addiction LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) AT (Completed)
    Trial results: View results
    EudraCT Number: 2006-000713-37 Sponsor Protocol Number: 127 Start Date*: 2006-02-20
    Sponsor Name:POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
    Full Title: Intervention Baclofen Intervention Study
    Medical condition: treatment of dependence in alcohol addiction
    Disease: Version SOC Term Classification Code Term Level
    9.1 10001639 Alcoholism LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-004686-26 Sponsor Protocol Number: 0594-020 Start Date*: 2009-07-29
    Sponsor Name:Merck & Co., Inc.
    Full Title: Ensayo clínico multicéntrico, aleatorizado, doble ciego, en fase II y en dos etapas para evaluar la eficacia y la seguridad de MK-0594 en pacientes con alcoholismo. A Phase II Multicenter, Randomi...
    Medical condition: Dependencia Alcohólica Alcohol Dependence
    Disease: Version SOC Term Classification Code Term Level
    9.1 10001594 Alcohol dependence syndrome LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed) BE (Completed) DE (Prematurely Ended) FR (Completed)
    Trial results: View results
    EudraCT Number: 2006-007090-72 Sponsor Protocol Number: lpdc07 Start Date*: 2007-10-17
    Sponsor Name:Central Institute of Mental Health
    Full Title: The role of the glutamatergic system in the extinction of conditioned reinforcement processes
    Medical condition: Alcohol-dependence is an important factor contributing to health care costs. Alcohol-dependent patients show conditioned reactions to stimuli that were associated with substance consumption and sev...
    Disease: Version SOC Term Classification Code Term Level
    9.1 10001594 Alcohol dependence syndrome LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2013-004024-11 Sponsor Protocol Number: 60-60600-97-103 Start Date*: 2014-07-23
    Sponsor Name:Academic Psychiatric Center - AMC-UvA
    Full Title: New pharmacotherapeutic treatment options for crack-cocaine dependent people in the Netherlands: A double-blind, placebo-controlled randomized feasibility study of sustained release dexamphetamine
    Medical condition: cocaine dependence (according DSM-IV)
    Disease: Version SOC Term Classification Code Term Level
    17.0 100000004873 10009817 Cocaine dependence LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: NL (Completed)
    Trial results: View results
    EudraCT Number: 2007-002334-11 Sponsor Protocol Number: 12014A Start Date*: 2009-03-13
    Sponsor Name:H. Lundbeck A/S
    Full Title: Nalmefene Efficacy Study I: Randomised, double-blind, placebo-controlled, parallel-group, efficacy study of 20 mg nalmefene, as needed use, in patients with alcohol dependence
    Medical condition: Alcohol dependence
    Disease: Version SOC Term Classification Code Term Level
    9.1 10001594 Alcohol dependence syndrome LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Completed) SE (Completed) FI (Completed) DE (Completed)
    Trial results: View results
    EudraCT Number: 2017-000736-33 Sponsor Protocol Number: CAFQ056X2201 Start Date*: 2017-10-25
    Sponsor Name:Novartis Farmacéutica S.A.
    Full Title: A randomized, subject and investigator blinded, placebo-controlled, parallel group study to investigate whether AFQ056 reduces cocaine use in patients diagnosed with Cocaine Use Disorder (CUD).
    Medical condition: Cocaine Use Disorder according to DSM 5
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000173266 10009815 Cocaine addiction LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2009-015537-67 Sponsor Protocol Number: 2009-08-17 Start Date*: 2009-11-23
    Sponsor Name:Universitätsmedizin der Johannes Gutenberg-Universität Mainz
    Full Title: Untersuchung der Wirksamkeit und Sicherheit von Vareniclin in der Postakutbehandlung der Alkoholabhängigkeit - eine prospektive, bizentrische, doppelblinde, placebokontrollierte, randomisierte Phas...
    Medical condition: Alcohol dependence
    Disease: Version SOC Term Classification Code Term Level
    14.1 10037175 - Psychiatric disorders 10001594 Alcohol dependence syndrome LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2013-000208-41 Sponsor Protocol Number: TV1380-COA-201 Start Date*: 2013-09-17
    Sponsor Name:Teva Pharmaceutical Industries Ltd.
    Full Title: A 12-week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Once-Weekly Intra-Muscular Injections of TV-1380 (150 mg/week or 30...
    Medical condition: Treatment for Facilitation of Abstinence in Cocaine-Dependent Subjects
    Disease: Version SOC Term Classification Code Term Level
    16.0 100000004873 10009815 Cocaine addiction LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2009-015837-55 Sponsor Protocol Number: RAA09-004 Start Date*: 2010-08-17
    Sponsor Name:Kings College London [...]
    1. Kings College London
    2. South London and Maudsley NHS Foundation Trust
    Full Title: Double-blind, 36 month, placebo-controlled trial of mifepristone on cognition in alcoholics
    Medical condition: Alcoholism
    Disease: Version SOC Term Classification Code Term Level
    18.0 10037175 - Psychiatric disorders 10001639 Alcoholism PT
    Population Age: Adults Gender: Male
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2007-002563-27 Sponsor Protocol Number: 12023A Start Date*: 2008-11-24
    Sponsor Name:H. Lundbeck A/S
    Full Title: Nalmefene Efficacy Study II: Randomised, double-blind, placebo-controlled, parallel-group, efficacy study of 20 mg nalmefene, as needed use, in patients with alcohol dependence
    Medical condition: Alcohol dependence
    Disease: Version SOC Term Classification Code Term Level
    9.1 10001594 Alcohol dependence syndrome LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed) PT (Completed) ES (Completed) IT (Completed) BE (Completed) PL (Completed) CZ (Completed)
    Trial results: View results
    EudraCT Number: 2007-002315-92 Sponsor Protocol Number: 12013A Start Date*: 2008-11-12
    Sponsor Name:H. Lundbeck A/S
    Full Title: A 52-week, randomised, double-blind, placebo-controlled, parallel-group, safety, tolerability and efficacy study of nalmefene, as needed use, in patients with alcohol dependence
    Medical condition: Alcohol dependence
    Disease: Version SOC Term Classification Code Term Level
    9.1 10001594 Alcohol dependence syndrome LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: CZ (Completed) SK (Completed) EE (Completed) GB (Completed) LV (Completed) HU (Completed) LT (Completed)
    Trial results: View results
    EudraCT Number: 2008-005318-35 Sponsor Protocol Number: 172009 Start Date*: 2009-01-29
    Sponsor Name:Schering-Plough Research Institute
    Full Title: A prospective, double-blind, placebo-controlled trial investigating the efficacy and safety of Org 25935 in relapse prevention in subjects with alcohol dependence.
    Medical condition: Alcoholism
    Disease: Version SOC Term Classification Code Term Level
    9.1 10001639 Alcoholism LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: FI (Prematurely Ended) SE (Prematurely Ended) DE (Prematurely Ended) NL (Prematurely Ended) BE (Completed) IT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2009-012261-61 Sponsor Protocol Number: 2009-4-CC Start Date*: 2009-08-20
    Sponsor Name:Academic Medical Center
    Full Title: Why methylphenidate is not successful in cocaine-dependent ADHD patients: a SPECT study comparing DAT before and after methylphenidate treatment in ADHD patients with and without cocaine dependence
    Medical condition: ADHD with and without substance use disorder (SUD)
    Disease: Version SOC Term Classification Code Term Level
    9.1 10064104 ADHD LLT
    9.1 10009815 Cocaine addiction LLT
    Population Age: Adults Gender: Male
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sun Jul 13 18:10:44 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA